Colevas S, Thompson J, Glazer T, et al. - Researchers conducted this retrospective chart review to better understand the significance of pain as a predictor of disease severity in parotid gland malignancy. The sample consisted of patients treated for primary parotid gland malignancy at the institution between 1991 and 2020. Retrospectively, patient records were reviewed and relevant clinical parameters were gathered. There were 69 patients in the low stage group and 80 patients in the high stage group, out of 154 patients assessed. It was noted that 37 high stage patients presented with pain. For patients with parotid gland malignancy, presentational pain seems to be a poor prognostic factor. Pain is independently related to increased risk of recurrence and decreased disease‐free survival time for patients with demonstrated high stage disease.